1 |
Ben Nasr H, Chahed K, Remadi S, Zakhama A, Chouchane L (2009). Expression and clinical significance of latent membrane protein-1, matrix metalloproteinase-1 and Ets-1 transcription factor in tunisian nasopharyngeal carcinoma patients. Arch Med Res, 40, 196-203.
DOI
ScienceOn
|
2 |
Bonta PI, Pols TW, van Tiel CM, et al (2010). Nuclear receptor Nurr1 is expressed in and is associated with human restenosis and inhibits vascular lesion formation in mice involving inhibition of smooth muscle cell proliferation and inflammation. Circulation, 121, 2023-32.
DOI
ScienceOn
|
3 |
Chua DT, Ma J, Sham JS, et al (2005). Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials. J Clin Oncol, 23, 1118-24.
DOI
ScienceOn
|
4 |
Chan AT (2010). Nasopharyngeal carcinoma. Ann Oncol, 21, 308-12.
|
5 |
Cao XJ, Hao JF, Yang XH, et al (2012). Prognostic value of expression of EGFR and nm23 for locoregionally advanced nasopharyngeal carcinoma. Med Oncol, 29, 263-71.
DOI
ScienceOn
|
6 |
Deutsch AJ, Angerer H, Fuchs TE, Neumeister P (2012). The nuclear orphan receptors NR4A as therapeutic target in cancer therapy. Anticancer Agents Med Chem, 12, 1001-14.
DOI
|
7 |
Holla VR, Mann JR, Shi Q, DuBois RN (2006). Prostaglandin E2 regulates the nuclear receptor NR4A2 in colorectal cancer. J Biol Chem, 281, 2676-82.
|
8 |
Inamoto T, Czerniak BA, Dinney CP, Kamat AM (2010). Cytoplasmic mislocalization of the orphan nuclear receptor Nurr1 is a prognostic factor in bladder cancer. Cancer, 116, 340-6.
DOI
ScienceOn
|
9 |
Ke N, Claassen G, Yu DH, et al (2004). Nuclear hormone receptor NR4A2 is involved in cell transformation and apoptosis. Cancer Res, 64, 8208-12.
DOI
ScienceOn
|
10 |
Kitagawa N, Kondo S, Wakisaka N, et al (2013). Expression of seven-in-absentia homologue 1 and hypoxia-inducible factor 1 alpha: Novel prognostic factors of nasopharyngeal carcinoma. Cancer Lett, 331, 52-7.
DOI
ScienceOn
|
11 |
Li H, Kolluri SK, Gu J, et al (2000). Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science, 289, 1159-64.
DOI
ScienceOn
|
12 |
Lin B, Kolluri SK, Lin F, et al (2004). Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell, 116, 527-40.
DOI
ScienceOn
|
13 |
Li XM, Huang WG, Yi H, Cheng AL, Xiao ZQ (2009). Proteomic analysis to identify cytokeratin 18 as a novel biomarker of nasopharyngeal carcinoma. J Cancer Res Clin Oncol, 135, 1763-75.
DOI
|
14 |
Li X, Tai HH (2009). Activation of thromboxane A2 receptors induces orphan nuclear receptor Nurr1 expression and stimulates cell proliferation in human lung cancer cells. Carcinogenesis, 30, 1606-13.
DOI
ScienceOn
|
15 |
Lee HS, Bae EJ, Yi SH, et al (2010). Foxa2 and Nurr1 synergistically yield A9 nigral dopamine neurons exhibiting improved differentiation, function, and cell survival. Stem Cells, 28, 501-12.
|
16 |
Maijenburg MW, Gilissen C, Melief SM, et al (2012). Nuclear receptors Nur77 and Nurr1 modulate mesenchymal stromal cell migration. Stem Cells Dev, 21, 228-38.
DOI
ScienceOn
|
17 |
Razak AR, Siu LL, Liu FF, et al (2010). Nasopharyngeal carcinoma: the next challenges. Eur J Cancer, 46, 1967-78.
DOI
ScienceOn
|
18 |
Sirin O, Lukov GL, Mao R, Conneely OM, Goodell MA (2010). The orphan nuclear receptor Nurr1 restricts the proliferation of haematopoietic stem cells. Nat Cell Biol, 12, 1213-9.
DOI
ScienceOn
|
19 |
Zhou J, Xiao X, Yi H, et al (2012). Upregulation of Gp96 correlates with the radiosensitivity and five-year survival rate of nasopharyngeal carcinoma. ORL J Otorhinolaryngol Relat Spec, 74, 164-71.
DOI
ScienceOn
|
20 |
Zhang T, Wang P, Ren H, Fan J, Wang G (2009). NGFI-B nuclear orphan receptor Nurr1 interacts with p53 and suppresses its transcriptional activity. Mol Cancer Res, 7, 1408-15.
DOI
ScienceOn
|
21 |
Brennan B (2006). Nasopharyngeal carcinoma. Orphanet J Rare Dis, 1, 23.
DOI
ScienceOn
|
22 |
Acikalin MF, Etiz D, Gurbuz MK, et al (2012). Prognostic significance of galectin-3 and cyclin D1 expression in undifferentiated nasopharyngeal carcinoma. Med Oncol, 29, 742-9.
DOI
ScienceOn
|